🏛️ Verified NIH Record • Updated 2025-11-12
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study (NCT05524428)
🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program Sponsor: Massachusetts General Hospital
🩺 Plain-English Summary (8th-Grade Level)
The investigators will use a mixed methods study i.e. focus groups involving CHC staff as well as quantitative study which involves analyzing data that is available from the EHR and DRVS population management platform.
Who can join: Review the eligibility criteria below.
Location: Codman Square Health Center — Boston, Massachusetts
Age range: 18 Years
🧪 Interventions in This Study
- Implementation Science Strategy (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Codman Square Health Center — Boston, Massachusetts
- Brockton Neighborhood Health Center — Brockton, Massachusetts
- East Boston Neighborhood Health Center — East Boston, Massachusetts
- Duffy Health Center — Hyannis, Massachusetts
📞 Contact the Study Coordinator
Phone: (617) 726-2426
Email: aanyane-yeboa@mgh.harvard.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colo-rectal Cancer
- EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer — Buffalo, New York
- Decision Counseling and Follow-up for Shield+ Patients — Philadelphia, Pennsylvania
- Colorectal Cancer Screening Outreach — New Haven, Connecticut
- A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE) — Gainesville, Florida
- Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery — Sacramento, California
Explore by condition: All Colo-rectal Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.